Jump Financial LLC Sells 116,140 Shares of Baxter International Inc. $BAX

Key Points

• Jump Financial LLC significantly reduced its stake in Baxter International by 83.5%, owning 22,888 shares valued at $783,000 after selling over 116,000 shares in the first quarter.
• Baxter International recently reported a quarterly earnings miss, posting $0.59 EPS against an expected $0.60, alongside revenues of $2.81 billion compared to a consensus of $2.82 billion.
• Analysts have revised their target prices for Baxter International, with Morgan Stanley and others cutting targets, resulting in a consensus rating of "Hold" with an average price target of $30.11.

Jump Financial LLC reduced its stake in Baxter International Inc. (NYSE:BAX - Free Report) by 83.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,888 shares of the medical instruments supplier's stock after selling 116,140 shares during the quarter. Jump Financial LLC's holdings in Baxter International were worth $783,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Zions Bancorporation National Association UT bought a new position in shares of Baxter International in the first quarter worth about $27,000. Rossby Financial LCC purchased a new stake in Baxter International in the 1st quarter worth approximately $29,000. MassMutual Private Wealth & Trust FSB raised its stake in Baxter International by 48.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 2,021 shares of the medical instruments supplier's stock worth $69,000 after acquiring an additional 656 shares during the period. Archer Investment Corp lifted its holdings in Baxter International by 20.5% during the first quarter. Archer Investment Corp now owns 2,935 shares of the medical instruments supplier's stock valued at $100,000 after purchasing an additional 500 shares in the last quarter. Finally, Bruce G. Allen Investments LLC lifted its holdings in Baxter International by 35.2% during the first quarter. Bruce G. Allen Investments LLC now owns 3,546 shares of the medical instruments supplier's stock valued at $121,000 after purchasing an additional 924 shares in the last quarter. Institutional investors own 90.19% of the company's stock.

Baxter International Price Performance

Shares of BAX traded up $0.06 during mid-day trading on Thursday, hitting $23.60. 3,103,271 shares of the stock were exchanged, compared to its average volume of 5,382,421. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.49 and a current ratio of 2.30. The company has a market cap of $12.12 billion, a PE ratio of -78.65, a price-to-earnings-growth ratio of 0.80 and a beta of 0.61. Baxter International Inc. has a 52-week low of $21.33 and a 52-week high of $40.49. The firm has a 50-day moving average of $26.53 and a two-hundred day moving average of $29.82.

Baxter International (NYSE:BAX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.01). Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The business had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $2.82 billion. During the same quarter in the prior year, the firm posted $0.68 EPS. The company's revenue for the quarter was up 4.3% on a year-over-year basis. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. On average, equities analysts predict that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, August 29th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.9%. Baxter International's dividend payout ratio (DPR) is presently -226.67%.

Wall Street Analyst Weigh In

Several analysts have recently commented on BAX shares. Morgan Stanley decreased their price objective on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Stifel Nicolaus restated a "hold" rating and issued a $25.00 price objective (down from $36.00) on shares of Baxter International in a research report on Monday, August 4th. Citigroup dropped their price objective on Baxter International from $34.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday, July 9th. Barclays decreased their target price on Baxter International from $41.00 to $36.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, Wells Fargo & Company dropped their price target on Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $30.11.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.